Literature DB >> 16257964

Differences in eNOS activity because of subcellular localization are dictated by phosphorylation state rather than the local calcium environment.

Jarrod E Church1, David Fulton.   

Abstract

Nitric oxide (NO) produced in the endothelium via the enzyme endothelial nitric-oxide synthase (eNOS) is an important vasoactive compound. Wild-type (WT) eNOS is localized to the plasma membrane and perinuclear/Golgi region by virtue of N-terminal myristoylation and palmitoylation. Acylation-deficient mutants (G2AeNOS) remain cytosolic and release less NO in response to Ca2+-elevating agonists; a disparity that we hypothesized was attributed to the greater distance between G2AeNOS and plasma membrane Ca2+ influx channels. The reduced activity of G2AeNOS versus WT was reversed upon disruption of cellular integrity with detergents or sonication. NO production from both constructs relied almost exclusively on the influx of extracellular Ca2+, and elevating intracellular Ca2+ to saturating levels with 10 microM ionomycin in the presence of 10 mM extracellular Ca2+ equalized NO production. To identify the contribution of calcium to the differences in activity between these enzymes, we created Ca2+/CaM-independent eNOS mutants by deleting the two putative autoinhibitory domains of eNOS. There was no difference in NO production between WT and G2A-targeted Ca2+-independent eNOS, suggesting that Ca2+ was the factor responsible. When eNOS constructs were fused in-frame to the bioluminescent probe aequorin, membrane-bound probes were exposed to higher [Ca2+] in unstimulated cells but upon ionomycin stimulation, the probes experienced equal amounts of Ca2+. The WT and G2A enzymes displayed significant differences in the phosphorylation state of Ser617, Ser635, and Ser1179, and mutating all three sites to alanine or restoring phosphorylation with the phosphatase inhibitor calyculin abolished the differences in activity. We therefore conclude that the disparity in NO production between WTeNOS and G2AeNOS is not caused by different localized [Ca2+] upon stimulation with ionomycin, but rather differences in phosphorylation state between the two constructs.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16257964     DOI: 10.1074/jbc.M505968200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  38 in total

Review 1.  The NO cascade, eNOS location, and microvascular permeability.

Authors:  Walter N Durán; Jerome W Breslin; Fabiola A Sánchez
Journal:  Cardiovasc Res       Date:  2010-05-11       Impact factor: 10.787

2.  Acute activation of eNOS by statins involves scavenger receptor-B1, G protein subunit Gi, phospholipase C and calcium influx.

Authors:  R Datar; W H Kaesemeyer; S Chandra; D J Fulton; R W Caldwell
Journal:  Br J Pharmacol       Date:  2010-08       Impact factor: 8.739

3.  Where is endothelial nitric oxide synthase more critical: plasma membrane or Golgi?

Authors:  Zheng-Gen Jin
Journal:  Arterioscler Thromb Vasc Biol       Date:  2006-05       Impact factor: 8.311

Review 4.  Subcellular targeting and trafficking of nitric oxide synthases.

Authors:  Stefanie Oess; Ann Icking; David Fulton; Roland Govers; Werner Müller-Esterl
Journal:  Biochem J       Date:  2006-06-15       Impact factor: 3.857

5.  Functional significance of cytosolic endothelial nitric-oxide synthase (eNOS): regulation of hyperpermeability.

Authors:  Fabiola A Sánchez; Roshniben Rana; Francisco G González; Toru Iwahashi; Ricardo G Durán; David J Fulton; Annie V Beuve; David D Kim; Walter N Durán
Journal:  J Biol Chem       Date:  2011-07-13       Impact factor: 5.157

6.  Mutation of protein kinase C phosphorylation site S1076 on alpha-subunits affects BK(Ca) channel activity in HEK-293 cells.

Authors:  Shu Zhu; Darren D Browning; Richard E White; David Fulton; Scott A Barman
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-07-10       Impact factor: 5.464

7.  An inhibitor of protein arginine methyltransferases, 7,7'-carbonylbis(azanediyl)bis(4-hydroxynaphthalene-2-sulfonic acid (AMI-1), is a potent scavenger of NADPH-oxidase-derived superoxide.

Authors:  Feng Chen; David J R Fulton
Journal:  Mol Pharmacol       Date:  2009-11-10       Impact factor: 4.436

8.  Inhibition of endothelial nitric oxide synthase by the lipid phosphatase PTEN.

Authors:  Jarrod E Church; Jin Qian; Sanjiv Kumar; Stephen M Black; Richard C Venema; Andreas Papapetropoulos; David J R Fulton
Journal:  Vascul Pharmacol       Date:  2009-12-03       Impact factor: 5.773

9.  TRPV4-mediated endothelial Ca2+ influx and vasodilation in response to shear stress.

Authors:  Suelhem A Mendoza; Juan Fang; David D Gutterman; David A Wilcox; Aaron H Bubolz; Rongshan Li; Makoto Suzuki; David X Zhang
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-12-04       Impact factor: 4.733

10.  Disruption of endothelial cell mitochondrial bioenergetics in lambs with increased pulmonary blood flow.

Authors:  Xutong Sun; Shruti Sharma; Sohrab Fratz; Sanjiv Kumar; Ruslan Rafikov; Saurabh Aggarwal; Olga Rafikova; Qing Lu; Tantiana Burns; Sridevi Dasarathy; Johnny Wright; Christian Schreiber; Monique Radman; Jeffrey R Fineman; Stephen M Black
Journal:  Antioxid Redox Signal       Date:  2013-03-14       Impact factor: 8.401

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.